<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink">
    <mets:dmdSec ID="DMD2917494">
        <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
            <mets:xmlData>
                <mods xmlns="http://www.loc.gov/mods/v3" version="3.7" xmlns:vl="http://visuallibrary.net/vl">
                    <titleInfo>
                        <title>Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics</title>
                    </titleInfo>
                    <name type="personal">
                        <namePart type="given">Kristian</namePart>
                        <namePart type="family">Müller</namePart>
                        <nameIdentifier type="orcid" typeURI="http://orcid.org">0000-0002-7914-0625</nameIdentifier>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Georg</namePart>
                        <namePart type="family">Falck</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <typeOfResource>text</typeOfResource>
                    <genre authority="dini">article</genre>
                    <originInfo>
                        <dateIssued encoding="w3cdtf">2018</dateIssued>
                    </originInfo>
                    <language>
                        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
                    </language>
                    <abstract lang="eng">Strategies for site-specific modification of proteins have increased in number, complexity, and specificity over the last years. Such modifications hold the promise to broaden the use of existing biopharmaceuticals or to tailor novel proteins for therapeutic or diagnostic applications. The recent quest for next-generation antibody–drug conjugates (ADCs) sparked research into techniques with site selectivity. While purely chemical approaches often impede control of dosage or locus of derivatization, naturally occurring enzymes and proteins bear the ability of co- or post-translational protein modifications at particular residues, thus enabling unique coupling reactions or protein fusions. This review provides a general overview and focuses on chemo-enzymatic methods including enzymes such as formylglycine-generating enzyme, sortase, and transglutaminase. Applications for the conjugation of antibodies and antibody mimetics are reported. View Full-Text</abstract>
                    <subject>
                        <topic>chemo-enzymatic labeling</topic>
                        <topic>armed antibody</topic>
                        <topic>antibody coupling</topic>
                        <topic>antibody conjugation</topic>
                    </subject>
                    <classification authority="ddc">570</classification>
                    <relatedItem type="host">
                        <titleInfo>
                            <title>Antibodies</title>
                        </titleInfo>
                        <part>
                            <detail type="volume">
                                <number>7</number>
                            </detail>
                            <detail type="issue">
                                <number>1</number>
                            </detail>
                        </part>
                    </relatedItem>
                    <identifier type="issn">2073-4468</identifier>
                    <identifier type="MEDLINE">31544857</identifier>
                    <identifier type="ISI">000428503500004</identifier>
                    <identifier type="urn">urn:nbn:de:0070-pub-29174941</identifier>
                    <identifier type="doi">10.3390/antib7010004</identifier>
                    <accessCondition type="use and reproduction" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</accessCondition>
                    <recordInfo>
                        <recordIdentifier>bielefeld_pub_2917494</recordIdentifier>
                    </recordInfo>
                    <extension>
                        <vl:doctype>oaArticle</vl:doctype>
                    </extension>
                </mods>
            </mets:xmlData>
        </mets:mdWrap>
    </mets:dmdSec>
    <mets:fileSec>
        <mets:fileGrp USE="pdf upload">
            <mets:file MIMETYPE="application/pdf" ID="FILE0_bielefeld_pub_2917494">
                <mets:FLocat xlink:href="https://pub.uni-bielefeld.de/download/2917494/2917496/antibodies-07-00004.mueller.pdf" LOCTYPE="URL"/>
            </mets:file>
        </mets:fileGrp>
    </mets:fileSec>
    <mets:structMap TYPE="LOGICAL">
        <mets:div TYPE="document" ID="bielefeld_pub_2917494" DMDID="DMD2917494">
            <mets:fptr FILEID="FILE0_bielefeld_pub_2917494"/>
        </mets:div>
    </mets:structMap>
</mets:mets>
